ÂÜÀòÂÒÂ×

Thaddeus founded Tradewind in 2017 with the vision of translating research discoveries into novel therapeutics for cancer patients. He has served in leadership and business development roles with life science start-ups led drug discovery teams and managed patent portfolios. In addition to another fundraising, Thaddeus brought Tradewind through the Y Combinator accelerator program in Mountain View, California. With more than 20 years of cancer research experience, Thaddeus has authored 35 publications. He earned his Ph.D. in Cellular and Molecular Biology from the University of Toronto and trained in the laboratory of Nobel Laureate, J. Michael Bishop at the University of California, San Francisco.